Open access
Oct 2026
ADHERE-DM: Assessing Bupropion for self-care adherence and glycaemic control in multimorbid type 2 diabetes mellitus with mild depression: A cross-over randomised controlled trial
Adding Bupropion to standard therapy for treatment of T2DM with mild depression, does not offer any benefit in terms of glycaemic control and self-care adherence.
M. A. Shamim, Ravindra Shukla, M. Swami et al.
· The Indian journal of medica... · 0 citations